Dexfadrostat

N/A

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameDexfadrostat
Drug Alias Namealdosterone synthase inhibitor (Novartis)CGS-020286AFAD-286
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A